Immunotherapy in HER2-positive breast cancer: state of the art and future perspectives

Breast cancer (BC) is a complex disease with primary or acquired incurability characteristics in a significant part of patients. Immunotherapeutical agents represent an emerging option for breast cancer treatment, including the human epidermal growth factor 2 positive (HER2+) subtype. The immune sys...

Descripción completa

Detalles Bibliográficos
Autores principales: Krasniqi, E., Barchiesi, G., Pizzuti, L., Mazzotta, M., Venuti, A., Maugeri-Saccà, M., Sanguineti, G., Massimiani, G., Sergi, D., Carpano, S., Marchetti, P., Tomao, S., Gamucci, T., De Maria, R., Tomao, F., Natoli, C., Tinari, N., Ciliberto, G., Barba, M., Vici, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6820969/
https://www.ncbi.nlm.nih.gov/pubmed/31665051
http://dx.doi.org/10.1186/s13045-019-0798-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6820969/
https://www.ncbi.nlm.nih.gov/pubmed/31665051
http://dx.doi.org/10.1186/s13045-019-0798-2

Ejemplares similares